Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle
- PMID: 2829215
- PMCID: PMC279709
- DOI: 10.1073/pnas.85.4.1086
Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle
Abstract
We have utilized antibody probes to examine the expression of DNA topoisomerases I and II and chromosome scaffold protein Sc-2 in normal and transformed cells. Neither topoisomerase I nor Sc-2 shows significant fluctuations in content or stability across the cell cycle. In contrast, topoisomerase II undergoes significant cell cycle-dependent alterations in both amount and stability. As cells progress from mitosis into G1, much of the topoisomerase II is degraded. During the first 2 hr of G1, the half life of topoisomerase II is decreased from that measured in asynchronous cell populations by a factor of 7. This suggests that the chromosome condensation/decondensation cycle is coupled to a parallel cycle of synthesis and degradation of topoisomerase II. In control experiments, we also found that the half-life of topoisomerase II is shorter in normal cells than in transformed cells by a factor of 4. Since the number of copies of topoisomerase II per cell is also lower in normal cells, this suggests that control of topoisomerase II stability is altered upon transformation. The stability of topoisomerase I and Sc-2 does not differ significantly between normal and transformed cells.
Similar articles
-
Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung.Biochim Biophys Acta. 1995 Dec 27;1264(3):337-46. doi: 10.1016/0167-4781(95)00171-9. Biochim Biophys Acta. 1995. PMID: 8547322
-
Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells.Cell Growth Differ. 1991 Apr;2(4):209-14. Cell Growth Differ. 1991. PMID: 1651102
-
Higher expression of topoisomerase II in lung cancers than normal lung tissues: different expression pattern from topoisomerase I.Biochem Biophys Res Commun. 1993 Aug 31;195(1):409-14. doi: 10.1006/bbrc.1993.2058. Biochem Biophys Res Commun. 1993. PMID: 8395833
-
[Poisons of DNA topoisomerases I and II].Bull Cancer. 1993 Nov;80(11):923-54. Bull Cancer. 1993. PMID: 8081034 Review. French.
-
Cell Cycle-Dependent Control and Roles of DNA Topoisomerase II.Genes (Basel). 2019 Oct 30;10(11):859. doi: 10.3390/genes10110859. Genes (Basel). 2019. PMID: 31671531 Free PMC article. Review.
Cited by
-
Human cytomegalovirus induces expression of cellular topoisomerase II.J Virol. 1990 Jan;64(1):9-15. doi: 10.1128/JVI.64.1.9-15.1990. J Virol. 1990. PMID: 2152837 Free PMC article.
-
Expression of the type I DNA topoisomerase gene in adenovirus-5 infected human cells.Nucleic Acids Res. 1990 Feb 25;18(4):801-8. doi: 10.1093/nar/18.4.801. Nucleic Acids Res. 1990. PMID: 2156232 Free PMC article.
-
Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA.Nucleic Acids Res. 1991 Jun 25;19(12):3295-300. doi: 10.1093/nar/19.12.3295. Nucleic Acids Res. 1991. PMID: 1905803 Free PMC article.
-
Mitotic phosphorylation stimulates DNA relaxation activity of human topoisomerase I.J Biol Chem. 2008 Jun 13;283(24):16711-22. doi: 10.1074/jbc.M802246200. Epub 2008 Apr 11. J Biol Chem. 2008. PMID: 18408216 Free PMC article.
-
Immunohistochemical study of DNA topoisomerase II in human gastric disorders.Am J Pathol. 1996 Sep;149(3):997-1007. Am J Pathol. 1996. PMID: 8780403 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials